blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3749296

EP3749296 - ESTERS OF HYDROXY-BENZOIC ACIDS FOR USE IN THE TREATMENT OF RHINOVIRUS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.09.2022
Database last updated on 24.01.2025
FormerThe patent has been granted
Status updated on  08.10.2021
FormerGrant of patent is intended
Status updated on  09.06.2021
FormerRequest for examination was made
Status updated on  13.11.2020
FormerThe international publication has been made
Status updated on  17.08.2019
Formerunknown
Status updated on  06.03.2019
Most recent event   Tooltip27.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 30.10.2024  [2024/44]
Applicant(s)For all designated states
Enzymatica AB
Ideon Science Park
223 70 Lund / SE
[2020/51]
Inventor(s)01 / LINDBERG, Fredrik
Danzigervägen 11
239 40 Falsterbo / SE
02 / STHENGEL, Elisabeth
Karl X Gustavs gata 7
25438 Helsingborg / SE
 [2021/44]
Former [2020/51]01 / LINDBERG, Fredrik
Palsjovagen 7
22362 Lund / SE
02 / STHENGEL, Elisabeth
Karl X Gustavs gata 7
25438 Helsingborg / SE
Representative(s)Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
[N/P]
Former [2020/51]Potter Clarkson
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Application number, filing date19706408.207.02.2019
[2020/51]
WO2019EP53059
Priority number, dateGB2018000198207.02.2018         Original published format: GB 201801982
[2020/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019154937
Date:15.08.2019
Language:EN
[2019/33]
Type: A1 Application with search report 
No.:EP3749296
Date:16.12.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 15.08.2019 takes the place of the publication of the European patent application.
[2020/51]
Type: B1 Patent specification 
No.:EP3749296
Date:10.11.2021
Language:EN
[2021/45]
Search report(s)International search report - published on:EP15.08.2019
ClassificationIPC:A61K31/216, A61P31/16
[2020/51]
CPC:
A61K31/216 (EP); A61K38/4826 (US); A61K31/235 (US);
A61K45/06 (US); A61K9/006 (US); A61P31/16 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/51]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:ESTER VON HYDROXY-BENZOESÄUREN ZUR VERWENDUNG IN DER BEHANDLUNG VON RHINOVIRUS[2021/25]
English:ESTERS OF HYDROXY-BENZOIC ACIDS FOR USE IN THE TREATMENT OF RHINOVIRUS[2020/51]
French:ESTERS DE L'ACIDE HYDROXY-BENZOÏQUE POUR L'UTILISATION DANS LE TRAITEMENT DU RHINOVIRUS[2021/25]
Former [2020/51]ESTER VON HYDROXYBENZOESÄUREN ZUR VERWENDUNG BEI DER BEHANDLUNG DES RHINOVIRUS
Former [2020/51]ESTERS D'ACIDES HYDROXYBENZOÏQUES CONÇUS POUR UNE UTILISATION DANS LE TRAITEMENT DU RHINOVIRUS
Entry into regional phase28.07.2020National basic fee paid 
28.07.2020Designation fee(s) paid 
28.07.2020Examination fee paid 
Examination procedure28.07.2020Examination requested  [2020/51]
28.07.2020Date on which the examining division has become responsible
11.03.2021Amendment by applicant (claims and/or description)
10.06.2021Communication of intention to grant the patent
29.09.2021Fee for grant paid
29.09.2021Fee for publishing/printing paid
29.09.2021Receipt of the translation of the claim(s)
Opposition(s)11.08.2022No opposition filed within time limit [2022/42]
Fees paidRenewal fee
12.02.2021Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.02.2019
AL10.11.2021
AT10.11.2021
CY10.11.2021
CZ10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
MC10.11.2021
MK10.11.2021
MT10.11.2021
RO10.11.2021
RS10.11.2021
SI10.11.2021
SK10.11.2021
SM10.11.2021
IE07.02.2022
LU07.02.2022
PL07.02.2022
TR07.02.2022
ES08.02.2022
SE08.02.2022
BG10.02.2022
GR11.02.2022
BE28.02.2022
CH28.02.2022
DK28.02.2022
FR28.02.2022
LI28.02.2022
NO28.02.2022
NL01.03.2022
IS10.03.2022
PT10.03.2022
[2024/44]
Former [2024/42]HU07.02.2019
AL10.11.2021
AT10.11.2021
CY10.11.2021
CZ10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
MC10.11.2021
MK10.11.2021
RO10.11.2021
RS10.11.2021
SI10.11.2021
SK10.11.2021
SM10.11.2021
IE07.02.2022
LU07.02.2022
PL07.02.2022
TR07.02.2022
ES08.02.2022
SE08.02.2022
BG10.02.2022
GR11.02.2022
BE28.02.2022
CH28.02.2022
DK28.02.2022
FR28.02.2022
LI28.02.2022
NO28.02.2022
NL01.03.2022
IS10.03.2022
PT10.03.2022
Former [2024/25]HU07.02.2019
AL10.11.2021
AT10.11.2021
CY10.11.2021
CZ10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
MC10.11.2021
MK10.11.2021
RO10.11.2021
RS10.11.2021
SI10.11.2021
SK10.11.2021
SM10.11.2021
IE07.02.2022
LU07.02.2022
PL07.02.2022
ES08.02.2022
SE08.02.2022
BG10.02.2022
GR11.02.2022
BE28.02.2022
CH28.02.2022
DK28.02.2022
FR28.02.2022
LI28.02.2022
NO28.02.2022
NL01.03.2022
IS10.03.2022
PT10.03.2022
Former [2024/23]AL10.11.2021
AT10.11.2021
CY10.11.2021
CZ10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
MC10.11.2021
MK10.11.2021
RO10.11.2021
RS10.11.2021
SI10.11.2021
SK10.11.2021
SM10.11.2021
IE07.02.2022
LU07.02.2022
ES08.02.2022
SE08.02.2022
BG10.02.2022
GR11.02.2022
BE28.02.2022
CH28.02.2022
DK28.02.2022
FR28.02.2022
LI28.02.2022
NO28.02.2022
NL01.03.2022
IS10.03.2022
PT10.03.2022
Former [2024/20]AL10.11.2021
AT10.11.2021
CY10.11.2021
CZ10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
MC10.11.2021
RO10.11.2021
RS10.11.2021
SI10.11.2021
SK10.11.2021
SM10.11.2021
IE07.02.2022
LU07.02.2022
ES08.02.2022
SE08.02.2022
BG10.02.2022
GR11.02.2022
BE28.02.2022
CH28.02.2022
DK28.02.2022
FR28.02.2022
LI28.02.2022
NO28.02.2022
NL01.03.2022
IS10.03.2022
PT10.03.2022
Former [2023/22]AL10.11.2021
AT10.11.2021
CZ10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
MC10.11.2021
RO10.11.2021
RS10.11.2021
SI10.11.2021
SK10.11.2021
SM10.11.2021
IE07.02.2022
LU07.02.2022
ES08.02.2022
SE08.02.2022
BG10.02.2022
GR11.02.2022
BE28.02.2022
CH28.02.2022
DK28.02.2022
FR28.02.2022
LI28.02.2022
NO28.02.2022
NL01.03.2022
IS10.03.2022
PT10.03.2022
Former [2023/10]AL10.11.2021
AT10.11.2021
CZ10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
MC10.11.2021
RO10.11.2021
RS10.11.2021
SI10.11.2021
SK10.11.2021
SM10.11.2021
IE07.02.2022
LU07.02.2022
SE08.02.2022
BG10.02.2022
GR11.02.2022
BE28.02.2022
CH28.02.2022
DK28.02.2022
FR28.02.2022
LI28.02.2022
NO28.02.2022
NL01.03.2022
IS10.03.2022
PT10.03.2022
Former [2023/09]AL10.11.2021
AT10.11.2021
CZ10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
MC10.11.2021
RO10.11.2021
RS10.11.2021
SI10.11.2021
SK10.11.2021
SM10.11.2021
IE07.02.2022
LU07.02.2022
SE08.02.2022
BG10.02.2022
GR11.02.2022
CH28.02.2022
DK28.02.2022
FR28.02.2022
LI28.02.2022
NO28.02.2022
NL01.03.2022
IS10.03.2022
PT10.03.2022
Former [2023/07]AL10.11.2021
AT10.11.2021
CZ10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
MC10.11.2021
RO10.11.2021
RS10.11.2021
SI10.11.2021
SK10.11.2021
SM10.11.2021
LU07.02.2022
SE08.02.2022
BG10.02.2022
GR11.02.2022
DK28.02.2022
FR28.02.2022
NO28.02.2022
NL01.03.2022
IS10.03.2022
PT10.03.2022
Former [2023/03]AL10.11.2021
AT10.11.2021
CZ10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
MC10.11.2021
RO10.11.2021
RS10.11.2021
SI10.11.2021
SK10.11.2021
SM10.11.2021
LU07.02.2022
SE08.02.2022
BG10.02.2022
GR11.02.2022
FR28.02.2022
NO28.02.2022
NL01.03.2022
IS10.03.2022
PT10.03.2022
Former [2023/02]AL10.11.2021
AT10.11.2021
CZ10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
MC10.11.2021
RO10.11.2021
RS10.11.2021
SI10.11.2021
SK10.11.2021
SM10.11.2021
LU07.02.2022
SE08.02.2022
BG10.02.2022
GR11.02.2022
NO28.02.2022
NL01.03.2022
IS10.03.2022
PT10.03.2022
Former [2023/01]AL10.11.2021
AT10.11.2021
CZ10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
MC10.11.2021
RO10.11.2021
RS10.11.2021
SI10.11.2021
SK10.11.2021
SM10.11.2021
LU07.02.2022
SE08.02.2022
BG10.02.2022
GR11.02.2022
NO28.02.2022
IS10.03.2022
PT10.03.2022
Former [2022/49]AL10.11.2021
AT10.11.2021
CZ10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
MC10.11.2021
RO10.11.2021
RS10.11.2021
SK10.11.2021
SM10.11.2021
LU07.02.2022
SE08.02.2022
BG10.02.2022
GR11.02.2022
NO28.02.2022
IS10.03.2022
PT10.03.2022
Former [2022/47]AT10.11.2021
CZ10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
MC10.11.2021
RO10.11.2021
RS10.11.2021
SK10.11.2021
SM10.11.2021
LU07.02.2022
SE08.02.2022
BG10.02.2022
GR11.02.2022
NO28.02.2022
IS10.03.2022
PT10.03.2022
Former [2022/44]AT10.11.2021
CZ10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
MC10.11.2021
RS10.11.2021
SK10.11.2021
SM10.11.2021
BG10.02.2022
GR11.02.2022
IS10.03.2022
PT10.03.2022
Former [2022/36]AT10.11.2021
CZ10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
RS10.11.2021
SK10.11.2021
SM10.11.2021
BG10.02.2022
GR11.02.2022
IS10.03.2022
PT10.03.2022
Former [2022/34]AT10.11.2021
EE10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
RS10.11.2021
SM10.11.2021
BG10.02.2022
GR11.02.2022
IS10.03.2022
PT10.03.2022
Former [2022/33]AT10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
RS10.11.2021
SM10.11.2021
BG10.02.2022
GR11.02.2022
IS10.03.2022
PT10.03.2022
Former [2022/24]AT10.11.2021
FI10.11.2021
HR10.11.2021
LT10.11.2021
LV10.11.2021
RS10.11.2021
BG10.02.2022
GR11.02.2022
IS10.03.2022
PT10.03.2022
Former [2022/22]AT10.11.2021
FI10.11.2021
LT10.11.2021
RS10.11.2021
BG10.02.2022
Former [2022/21]AT10.11.2021
RS10.11.2021
BG10.02.2022
Former [2022/19]BG10.02.2022
Cited inInternational search[A]WO9858627  (EBELING SABINE [DE], et al) [A] 1-65 * figure 3 *
 [A]  - MAUGERI ET AL, "New anti-viral drugs for the treatment of the common cold", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, (20071223), vol. 16, no. 6, doi:10.1016/J.BMC.2007.12.030, ISSN 0968-0896, pages 3091 - 3107, XP022558544 [A] 1-65 * table 3 * * page 3091, abstract *

DOI:   http://dx.doi.org/10.1016/j.bmc.2007.12.030
 [A]  - CHOI H J ET AL, "Anti-human rhinovirus activity of gallic acid possessing antioxidant capacity", PHYTOTHERAPY RESEARCH, WILEY, UK, (20120201), doi:10.1002/PTR.3101, ISSN 0951-418X, pages 1292 - 1296, XP018503081 [A] 1-65 * abstract *

DOI:   http://dx.doi.org/10.1002/ptr.3101
by applicantWO2017017012
 EP1202743
 WO2015150799
 US4235871
 US5851451
 EP0213303
    - CHOI et al., Phytother. Res., (20100000), vol. 24, no. 9, pages 1292 - 6
    - STEFANSSON et al., Comparative Biochem. Physiol: Part B - Biochem. & Mol. Biol., (20100000), vol. 155, no. 2, pages 186 - 194
    - ASGEIRSSON et al., Eur. J. Biochem., (19890000), vol. 180, pages 85 - 94
    - "GenBank", Database accession no. AC090397
    - STEFANSSON et al., Comp. Biochem. Physiol. B, Biochem. Mol. Biol., (20100000), vol. 155, no. 2, pages 186 - 194
    - ASGEIRSSON; BJARNASON, Comp. Biochem. Physiol. B, (19910000), vol. 998, pages 327 - 335
    - GU6MUNDSD6TTIR et al., Eur J Biochem., (19930000), vol. 217, no. 3, pages 1091 - 7
    - STEFANSSON et al., Biochim Biophys Acta, (20170000), vol. 1865, no. 1, pages 11 - 19
    - PALSDOTTIR; GUDMUNDSDOTTIR, Food Chem., (20080000), vol. 111, no. 2, pages 408 - 14
    - "Uniprot", Database accession no. P16049-1
    - "Genbank", Database accession no. Q91041.2
    - "Genbank", Database accession no. AOX15769.1
    - STEFANSSON et al., Comp Biochem Physiol B Biochem Mol Biol., (20100000), vol. 155, no. 2, pages 186 - 94
    - THOMPSON et al., Nuc. Acid Res., (19940000), vol. 22, pages 4673 - 4680
    - MEZIERE et al., J. Immunol., (19970000), vol. 159, pages 3230 - 3237
    - VEBER et al., Proc. Natl. Acad. Sci. USA, (19780000), vol. 75, page 2636
    - THORSETT et al., Biochem. Biophys. Res. Comm., (19830000), vol. 111, page 166
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.